MICROBIAL PATHOGENESIS

Scope & Guideline

Transforming Understanding into Therapeutic Strategies

Introduction

Delve into the academic richness of MICROBIAL PATHOGENESIS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0882-4010
PublisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1986 to 2024
AbbreviationMICROB PATHOGENESIS / Microb. Pathog.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address24-28 OVAL RD, LONDON NW1 7DX, ENGLAND

Aims and Scopes

MICROBIAL PATHOGENESIS focuses on the complex interactions between microbes and their hosts, emphasizing the mechanisms of pathogenesis, host response, and the development of novel therapeutic strategies. The journal aims to publish high-quality research that advances our understanding of microbial diseases and explores innovative approaches for prevention and treatment.
  1. Microbial Pathogenesis Mechanisms:
    Research exploring the molecular and cellular mechanisms by which pathogens cause disease, including the study of virulence factors and host-pathogen interactions.
  2. Antimicrobial Resistance:
    Investigations into the mechanisms of resistance in various microbial species, including bacteria, fungi, and viruses, alongside strategies to combat resistance.
  3. Therapeutic Innovations:
    Development and evaluation of new therapeutic strategies, including vaccines, antimicrobial peptides, and phage therapy, aimed at treating infections caused by pathogenic microbes.
  4. Microbiome Research:
    Studies focusing on the role of the microbiome in health and disease, particularly how gut and environmental microbiota interact with pathogens and influence disease outcomes.
  5. Zoonotic Diseases:
    Research addressing the transmission and pathology of diseases that can be transmitted from animals to humans, emphasizing the importance of understanding these interactions for public health.
  6. Infectious Disease Epidemiology:
    Epidemiological studies aimed at understanding the prevalence, risk factors, and transmission dynamics of infectious diseases, particularly in specific populations.
The journal has embraced several emerging themes that reflect current trends in microbial research. These themes highlight the journal's commitment to addressing contemporary challenges in microbial pathogenesis and therapeutics.
  1. Environmental Microbiology:
    There is an increasing interest in the role of environmental factors and microbiota in disease processes, particularly in the context of climate change and its impact on microbial behavior.
  2. Host-Microbiome Interactions:
    Research focusing on the intricate relationships between the host's immune system and its microbiota is gaining traction, showcasing how these interactions can influence disease outcomes.
  3. Vaccine Development:
    A notable trend is the focus on innovative vaccine strategies, including multi-epitope vaccines and the use of adjuvants, reflecting the urgent need for effective vaccines against emerging infectious diseases.
  4. Nanotechnology in Microbial Control:
    The application of nanotechnology for developing new antimicrobial agents and delivery systems is on the rise, providing novel ways to combat drug-resistant pathogens.
  5. Immunotherapy:
    Emerging studies are exploring the potential of immunotherapies, including the use of monoclonal antibodies and immune modulators, in treating infectious diseases and their complications.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have seen a decline in focus over recent years. This may reflect shifts in research priorities or the emergence of new, more pressing topics within the field.
  1. Traditional Antibiotics:
    There has been a noticeable decline in studies solely focused on conventional antibiotics, as researchers shift towards exploring alternative therapies like phage therapy and antimicrobial peptides.
  2. Single Pathogen Studies:
    Research focusing exclusively on individual pathogens without considering their interactions within the microbiome or with host systems is waning, as there is a growing recognition of the complexity of microbial ecosystems.
  3. Basic Pathogen Characterization:
    The focus on basic characterization of pathogens, such as morphology and biochemical properties, is decreasing in favor of more integrative approaches that include genomic and proteomic analyses.

Similar Journals

MICROBIOLOGICAL RESEARCH

Pioneering Insights in Microbiology Research
Publisher: ELSEVIER GMBHISSN: 0944-5013Frequency: 12 issues/year

MICROBIOLOGICAL RESEARCH, published by Elsevier GmbH, serves as a leading platform for advancements in the field of Microbiology, holding an impressive Q1 ranking in its category as of 2023. With an ISSN of 0944-5013 and E-ISSN 1618-0623, this journal has been instrumental in disseminating high-quality research since its inception in 1994 and continues to contribute significantly to the academic landscape through 2024. Positioned within the top 13% of publications in the Immunology and Microbiology category, ranked #24 out of 182 according to Scopus, it attracts the attention of researchers, professionals, and students alike. While the journal is not open access, it offers vital insights and peer-reviewed articles that drive innovation and exploration within microbiological research. Its rigorous selection process underscores the importance of quality and relevance in advancing knowledge in this dynamic field.

JOURNAL OF INFECTION

Leading the Charge in Infectious Disease Scholarship
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

MIKROBIYOLOJI BULTENI

Pioneering Insights in Immunology and Microbiology
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Microbiology Research

Unlocking the Secrets of Microbes for a Better Tomorrow
Publisher: MDPIISSN: Frequency: 4 issues/year

Microbiology Research, published by MDPI, stands as a pivotal open-access journal in the field of microbiology, having established its presence since 2010. Based in Switzerland, this journal strives to provide a platform for innovative research and cutting-edge findings in various branches of microbiology, including medical microbiology and molecular biology. With an impact factor that reflects its dedication to scholarly excellence, Microbiology Research is classified in the Q3 category for both microbiology and medical microbiology, and Q4 for molecular biology as of 2023, indicating its growing importance and outreach within these domains. The journal aims to foster discussion and collaboration among researchers, professionals, and students by presenting articles that cover a wide array of topics and methodologies in microbiological research. Leveraging its open-access model, Microbiology Research ensures that high-quality research is accessible to a global audience, thus facilitating the advancement of knowledge and innovation in the microbial sciences.

REVISTA ARGENTINA DE MICROBIOLOGIA

Exploring the frontiers of microbiology and medicine since 1979.
Publisher: ASOCIACION ARGENTINA MICROBIOLOGIAISSN: 0325-7541Frequency: 4 issues/year

REVISTA ARGENTINA DE MICROBIOLOGIA, published by the ASOCIACION ARGENTINA MICROBIOLOGIA, stands as a prominent open-access journal in the field of microbiology and medicine since its establishment in 1979. With an ISSN of 0325-7541 and an E-ISSN of 1851-7617, this journal has paved the way for disseminating high-quality research while enhancing accessibility for academics and practitioners worldwide. The journal has achieved notable rankings, being classified in Q3 for Medicine (miscellaneous) and Q3 for Medical Microbiology in 2023, reflecting its commitment to advancing knowledge in these critical areas. Despite its relatively modest impact factors, it occupies a vital niche in the academic landscape, fostering collaborations and innovative research among experts. With Open Access available since 2013, REVISTA ARGENTINA DE MICROBIOLOGIA not only facilitates widespread distribution of valuable scientific information but also empowers researchers, professionals, and students to stay abreast of the latest findings and developments in microbiology. For those engaged in the evolving realm of microbiology, this journal serves as an essential resource for sharing insights and advancing the scientific community.

New Microbes and New Infections

Connecting global researchers to combat new infections.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

GERMS

Enhancing public health through collaborative research initiatives.
Publisher: EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASESISSN: 2248-2997Frequency: 4 issues/year

GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.

Reviews and Research in Medical Microbiology

Transforming Research into Clinical Practice
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2770-3150Frequency: 4 issues/year

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

Microbiology Spectrum

Fostering collaboration through open access innovation.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

BRAZILIAN JOURNAL OF MICROBIOLOGY

Advancing Microbial Knowledge Globally
Publisher: SPRINGERISSN: 1517-8382Frequency: 4 issues/year

The BRAZILIAN JOURNAL OF MICROBIOLOGY, published by SPRINGER, stands as a pivotal platform in the field of microbiology, offering an open access model since 2000. With the ISSN 1517-8382 and E-ISSN 1678-4405, this esteemed journal encourages the dissemination of groundbreaking research and innovative methodologies that contribute to the understanding of microbial life, its role in health and disease, and its environmental impact. Based in Switzerland and accessible globally, the journal’s categorization in the Q3 quartile for Microbiology reflects its commitment to quality and relevance in the scientific community. As of 2023, it ranks 121 out of 182 in the Scopus listings for Microbiology, further highlighting its growing influence in immunology and microbiological research. With converged years spanning from 1992 to 2024, the journal continues to support a diverse range of studies, making it an invaluable resource for researchers, professionals, and students alike.